腔内近距离放射治疗不可切除肝门部胆管癌后的长期生存：一例报告
Long-term survival after intraluminal brachytherapy for inoperable hilar cholangiocarcinoma: a case report.
作者信息
Chan Siu-Yin, Poon Ronnie T, Ng Kelvin K, Liu Chi-Leung, Chan Raymond T, Fan Sheung-Tat
机构信息
Centre for the Study of Liver Disease and Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong, China.
出版信息
World J Gastroenterol. 2005 May 28;11(20):3161-4. doi: 10.3748/wjg.v11.i20.3161.
Abstract
Surgical resection with a tumor-free margin is the only curative treatment for hilar cholangiocarcinoma (Klatskin tumor). However, over half of the patients present late with unresectable tumors. Radiotherapy using external beam irradiation or intraluminal brachytherapy (ILBT) has been used to treat unresectable hilar cholangiocarcinoma with satisfactory outcome. We reported a patient with unresectable hilar cholangiocarcinoma surviving more than 6 years after combined external beam irradiation and ILBT.
摘要
实现切缘无肿瘤的手术切除是肝门部胆管癌（Klatskin瘤）唯一的治愈性治疗方法。然而，超过半数的患者就诊时已处于晚期，肿瘤无法切除。使用外照射放疗或腔内近距离放疗（ILBT）的放射治疗已被用于治疗无法切除的肝门部胆管癌，疗效令人满意。我们报告了1例无法切除的肝门部胆管癌患者，在接受外照射放疗和ILBT联合治疗后存活超过6年。
相似文献
1
Long-term survival after intraluminal brachytherapy for inoperable hilar cholangiocarcinoma: a case report.腔内近距离放射治疗不可切除肝门部胆管癌后的长期生存：一例报告
World J Gastroenterol. 2005 May 28;11(20):3161-4. doi: 10.3748/wjg.v11.i20.3161.
2
Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.放疗联合金属支架置入治疗不可切除肝门部胆管癌的临床获益。
World J Gastroenterol. 2012 May 21;18(19):2364-70. doi: 10.3748/wjg.v18.i19.2364.
3
Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma.可切除肝门部胆管癌术后放疗的结果
World J Surg. 2003 Feb;27(2):173-9. doi: 10.1007/s00268-002-6434-1.
4
Unresectable hilar cholangiocarcinoma: multimodality treatment with percutaneous and intraluminal plus external radiotherapy.不可切除的肝门部胆管癌：经皮和腔内联合外照射的多模式治疗
J Chemother. 2004 Nov;16 Suppl 5:55-7. doi: 10.1080/1120009x.2004.11782386.
5
Intraluminal brachytherapy in bile duct carcinomas.胆管癌的腔内近距离放射治疗
Aust N Z J Surg. 1996 Feb;66(2):74-7. doi: 10.1111/j.1445-2197.1996.tb01115.x.
6
Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis.不可切除的肝外胆管癌的腔内近距离放射治疗：意大利汇总分析。
Anticancer Res. 2020 Jun;40(6):3417-3421. doi: 10.21873/anticanres.14326.
7
Intraluminal brachytherapy in the treatment of bile duct carcinomas.腔内近距离放射疗法治疗胆管癌
Australas Radiol. 1997 May;41(2):151-4. doi: 10.1111/j.1440-1673.1997.tb00701.x.
8
[Palliative locoregional therapy for hilar cholangiocarcinoma: photodynamic therapy and brachytherapy].[肝门部胆管癌的姑息性局部治疗：光动力疗法和近距离放射疗法]
Zentralbl Chir. 2007 Aug;132(4):336-41. doi: 10.1055/s-2007-981202.
9
A systematic review of intraluminal high dose rate brachytherapy in the management of malignant biliary tract obstruction and cholangiocarcinoma.腔内高剂量率近距离放射治疗恶性胆道梗阻和胆管癌的系统评价。
Radiother Oncol. 2021 Dec;165:60-74. doi: 10.1016/j.radonc.2021.10.011. Epub 2021 Oct 23.
引用本文的文献
1
Unresectable hilar cholangiocarcinoma treated with chemoradiotherapy: a 9-year survival case.接受放化疗治疗的不可切除肝门部胆管癌：一例生存9年的病例。
Int Cancer Conf J. 2020 Sep 19;10(1):41-45. doi: 10.1007/s13691-020-00445-z. eCollection 2021 Jan.
2
Advances in endoscopic retrograde cholangiopancreatography for the treatment of cholangiocarcinoma.内镜逆行胰胆管造影术治疗胆管癌的进展
World J Gastrointest Endosc. 2015 Jun 25;7(7):675-87. doi: 10.4253/wjge.v7.i7.675.
3
Liver transplantation for hilar cholangiocarcinoma.肝移植治疗肝门部胆管癌。
World J Gastroenterol. 2013 Dec 28;19(48):9209-15. doi: 10.3748/wjg.v19.i48.9209.
4
Multimodal oncological therapy comprising stents, brachytherapy, and regional chemotherapy for cholangiocarcinoma.多模态肿瘤治疗包括胆管癌支架、近距离放疗和区域化疗。
Gut Liver. 2010 Sep;4 Suppl 1(Suppl 1):S82-8. doi: 10.5009/gnl.2010.4.S1.S82. Epub 2010 Sep 10.
本文引用的文献
1
A modern approach to malignant hilar biliary obstruction.恶性肝门部胆管梗阻的现代治疗方法。
Rev Gastroenterol Disord. 2003 Fall;3(4):187-201.
2
Role of radiology in the treatment of malignant hilar biliary strictures 2: 10 years of single-institution experience with percutaneous treatment.
Australas Radiol. 2003 Dec;47(4):393-403. doi: 10.1046/j.1440-1673.2003.01209.x.
3
Liver transplantation for hilar cholangiocarcinoma: Spanish experience.
Transplant Proc. 2003 Aug;35(5):1821-2. doi: 10.1016/s0041-1345(03)00724-3.
4
Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma.对部分无法切除的肝门部胆管癌患者进行肝移植的初步经验。
Surg Oncol Clin N Am. 2002 Oct;11(4):909-21. doi: 10.1016/s1055-3207(02)00036-4.
5
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.胆管癌诊疗指南：共识文件
Gut. 2002 Nov;51 Suppl 6(Suppl 6):VI1-9. doi: 10.1136/gut.51.suppl_6.vi1.
6
Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma.放化疗和移植可使不可切除的肝门部胆管癌患者获得长期生存。
Am J Transplant. 2002 Sep;2(8):774-9. doi: 10.1034/j.1600-6143.2002.20812.x.
7
High-dose-rate remote afterloading intracavitary brachytherapy for the treatment of extrahepatic biliary duct carcinoma.高剂量率远程后装腔内近距离放射治疗肝外胆管癌
Cancer J. 2002 Jan-Feb;8(1):74-8. doi: 10.1097/00130404-200201000-00013.
8
9
Management of hilar bile duct carcinoma.肝门部胆管癌的治疗
Hepatogastroenterology. 2001 Sep-Oct;48(41):1289-94.
10
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.225例肝门部胆管癌患者的分期、可切除性及预后
Ann Surg. 2001 Oct;234(4):507-17; discussion 517-9. doi: 10.1097/00000658-200110000-00010.
Zotero 插件